130 related articles for article (PubMed ID: 38163762)
1. PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study).
Di Salvo M; Santi Laurini G; Motola D; Valpiani G; Sapigni E; Pompilio A; Arzenton E; Marra A
Br J Clin Pharmacol; 2024 Apr; 90(4):1050-1057. PubMed ID: 38163762
[TBL] [Abstract][Full Text] [Related]
2. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
Turner S; Nunn AJ; Fielding K; Choonara I
Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
[TBL] [Abstract][Full Text] [Related]
4. Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs.
Dubrall D; Leitzen S; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B
BMC Pharmacol Toxicol; 2021 Oct; 22(1):56. PubMed ID: 34620231
[TBL] [Abstract][Full Text] [Related]
5. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
[TBL] [Abstract][Full Text] [Related]
8. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
9. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
Aagaard L; Hansen EH
Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
Viola E; Trifirò G; Ingrasciotta Y; Sottosanti L; Tari M; Giorgianni F; Moretti U; Leone R
Expert Opin Drug Saf; 2016 Dec; 15(sup2):61-67. PubMed ID: 27875919
[TBL] [Abstract][Full Text] [Related]
11. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.
Pérez-Ingidua C; Rivas-Paterna AB; González-Perrino C; Aleo-Luján E; Ascaso-Del-Rio A; Laredo-Velasco L; Portolés-Pérez A; Vargas-Castrillón E
BMC Pediatr; 2024 May; 24(1):344. PubMed ID: 38760745
[TBL] [Abstract][Full Text] [Related]
13. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A
BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234
[TBL] [Abstract][Full Text] [Related]
14. Off-label use of drugs in Italy: a prospective, observational and multicentre study.
Pandolfini C; Impicciatore P; Provasi D; Rocchi F; Campi R; Bonati M;
Acta Paediatr; 2002; 91(3):339-47. PubMed ID: 12022310
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
[TBL] [Abstract][Full Text] [Related]
16. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
[TBL] [Abstract][Full Text] [Related]
17. [Knowledge creation about adverse drug reactions in the paediatric population].
Aagaard L
Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239
[TBL] [Abstract][Full Text] [Related]
18. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
20. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
